Literature DB >> 22573565

Long-term outcome after first intestinal resection in pediatric-onset Crohn's disease: a population-based study.

Médina Boualit1, Julia Salleron, Dominique Turck, Mathurin Fumery, Guillaume Savoye, Jean-Louis Dupas, Eric Lerebours, Alain Duhamel, Véronique Merle, Antoine Cortot, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet, Corinne Gower-Rousseau.   

Abstract

BACKGROUND: To describe long-term postoperative evolution of pediatric-onset Crohn's disease (CD) and identify predictors of outcome we studied a population-based cohort (1988-2004) of 404 patients (0-17 years), of which 130 underwent surgery.
METHODS: Risks for a second resection and first need for immunosuppressors (IS) and/or biologics were estimated by survival analysis and Cox models used to determine predictors of outcome. Impact of time of first surgery on nutritional catch-up was studied using regression.
RESULTS: In all, 130 patients (70 females) with a median age at diagnosis of 14.2 years (interquartile range: 12-16) were followed for 13 years (9.4-16.6). Probability of a second resection was 8%, 17%, and 29% at 2, 5, and 10 years, respectively. In multivariate analysis, age <14, stenosing (B2) and penetrating (B3) behaviors and upper gastrointestinal location (L4) at diagnosis were associated with an increased risk of second resection. Probability of receiving IS or biologics was 18%, 34%, and 47% at 2, 5, and 10 years, respectively. In multivariate analysis, L4 was a risk factor for requiring IS or biologics, while surgery within 3 years after CD diagnosis was protective. Catch-up in height and weight was better in patients who underwent surgery within 3 years after CD diagnosis than those operated on later.
CONCLUSIONS: In this pediatric-onset CD study, mostly performed in a prebiologic era, a first surgery performed within 3 years after CD diagnosis was associated with a reduced need for IS and biologics and a better catch-up in height and weight compared to later surgery.

Entities:  

Mesh:

Year:  2013        PMID: 22573565     DOI: 10.1002/ibd.23004

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  4 in total

Review 1.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

2.  Outcomes of Primary Ileocolic Resection for Pediatric Crohn Disease in the Biologic Era.

Authors:  Elizabeth A Spencer; Lauren Jarchin; Priya Rolfes; Sergey Khaitov; Alexander Greenstein; Marla C Dubinsky
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-12-01       Impact factor: 2.839

Review 3.  Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts.

Authors:  Lester Tsai; Christopher Ma; Parambir S Dulai; Larry J Prokop; Samuel Eisenstein; Sonia L Ramamoorthy; Brian G Feagan; Vipul Jairath; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-27       Impact factor: 13.576

4.  Surgery in Pediatric Crohn Disease: Case Series from a Single Tertiary Referral Center.

Authors:  Rita Lourenço; Sara Azevedo; Ana Isabel Lopes
Journal:  GE Port J Gastroenterol       Date:  2016-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.